Activation of cPLA2 in the tumor microenvironment leads to increased vasculature and enhanced tumorogenesis leading to radioresistance of the tumor and diminishing the efficacy of the radiotherapy [23], [24]. The gene discussed is PLA2G4A; the disease is neoplasm.